Sepracor to Cut 300 Sales Jobs
The Marlborough, Mass.-based drugmaker Sepracor announced last week that it would cut 300 sales job due to poor third quarter earnings. Revenue for the quarter fell 1.9% to $283.95 million.
Sepracor manufactures and sells the well known sleep aid Lunesta which jumped 14% to $160.9 million from last year. However, sales of its respiratory product Xopenex HCL Inhalation Solution slid from $125.4 million to $94.4 million. The company announced the layoffs to reduce costs.
Looks like things are starting to slow down in the Boston area.
Until next time....
Good Luck and Good Job Hunting!!!!!!!!!!!!!
